Bio & Insurance Information

Dr. Darcy Spicer is a specialist in medical oncology in Los Angeles, California and he is affiliated with many regional hospitals, such as Keck Medical Center of USC and Los Angeles County-USC Medical Center. He graduated from University of Calgary Faculty of Medicine where he got his medical degree. He did a fellowship in medical oncology at University of Southern California - LAC+USC Medical Center. The doctor is board certified in internal medicine and medical oncology and he has a practical experience of more than 20 years.



Education & Training

University of Calgary Faculty of Medicine

Medical School

University of Southern California - LAC+USC Medical Center

Fellowship

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Oncology

Hospitals & Clinics

Keck Hospital of USC - Medical Center

Languages: English/Spanish

(323) 442-8500

1500 San Pablo St

Los Angeles, California 90033

Read More

LAC - USC Medical Center

Languages: English/Spanish

(323) 409-1000

2051 Marengo St.

Los Angeles, California 90033

Read More

USC Norris Comprehensive Cancer Center

Languages: English/Spanish

(323) 865-3000

1441 Eastlake Avenue

Los Angeles, California 90033

Read More

Publications

Dr. Darcy Spicer has contributed to 3 publications.

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.

Chung, K., Hovanessian-Larsen, L.J., Hawes, D., Taylor, D., Downey, S., Spicer, D.V., Stanczyk, F.Z., Patel, S., Anderson, A.R., Pike, M.C., Wu, A.H., Pearce, C.L.; Breast Cancer Res Treat. 2012 Apr.

See more >>

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women.

Lee, E., McKean-Cowdin, R., Ma, H., Spicer, D.V., Van Den Berg, D., Bernstein, L., Ursin, G.; J Clin Oncol. 2011 Nov 20.

See more >>

Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers.

Weitzel, J.N., Buys, S.S., Sherman, W.H., Daniels, A., Ursin, G., Daniels, J.R., MacDonald, D.J., Blazer, K.R., Pike, M.C., Spicer, D.V.; Clin Cancer Res. 2007 Jan 15.

See more >>

Memberships

American College of Physicians

American Society of Clinical Oncology